Filing Details
- Accession Number:
- 0001765581-25-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-03 19:13:20
- Reporting Period:
- 2025-02-27
- Filing Date:
- 2025-03-03
- Accepted Time:
- 2025-03-03 19:13:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1193210 | C Bruce Cozadd | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2025-02-27 | 30,814 | $0.00 | 470,558 | No | 4 | A | Direct | |
Ordinary Shares | Disposition | 2025-03-03 | 6,500 | $144.25 | 464,058 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on March 5, 2026.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.